Jared Gollob has been appointed chief medical officer of Cambridge, MA-based Kymera Therapeutics. Gollob most recently worked at Alnylam Pharmaceuticals (NASDAQ: [[ticker:ALNY]]) where he was vice president of clinical development and global vice president of medical affairs. Kymera is developing drugs based on protein degradation, the process cells use to rid themselves of harmful proteins.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
